Research Newsroom

Jasmine_HLHS Consortium web.jpg
Children's Hospital Los Angeles is announcing participation in the first-ever clinical trial using stem cells from umbilical cord blood to delay or even prevent heart failure in children born with a rare congenital heart defect that leaves them with half a heart. The Phase I...
Michael  Pulsipher, MD, CHLA3.jpg
Detailed analysis of patient data now available Results of the global, multicenter, pivotal phase 2 study that led to the first FDA approval of a gene therapy/cell therapy approach known as CAR T-cell therapy, were published on January 31 in the New England Journal of...
Laura Perin, PhD_0 (1) 2017 web.jpg
Study findings indicate a more effective way to slow organ damage in Alport syndrome Researchers have demonstrated for the first time that extracellular vesicles – tiny protein-filled structures – isolated from amniotic fluid stem cells (AFSCs) can be used to effectively...
CHLA-D.Brent Polk, MD.jpg
Findings may point to new treatment approaches for patients with IBD D. Brent Polk, MD, AGAF, an investigator at Children’s Hospital Los Angeles, has been awarded $1.5 million by the National Institute of Diabetes and Digestive and Kidney Diseases of the NIH for the study of...